GPR17 receptor modulators

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9879030
SERIAL NO

14399518

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Chemical compounds are provided which act on GPR17 receptors and are useful in the treatment or amelioration of chronic and/or acute neurodegenerative diseases, such as multiple sclerosis, inflammatory diseases, pathologies involving the immune system, cardiovascular diseases, and renal diseases.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNIVERSITA' DEGLI STUDI DI MILANO20122 MILANO
FONDAZIONE ITALIANA SCLEROSI MULTIPLA - FISM ONLUS16149 GENOVA

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Abbracchio, Maria Pia Milan, IT 3 3
Battaglia, Mario Alberto Genoa, IT 1 0
Eberini, Ivano Milan, IT 4 0
Fumagalli, Marta Milan, IT 1 0
Parravicini, Chiara Milan, IT 4 0
Sensi, Cristina Milan, IT 1 0
Zaratin, Paola Genoa, IT 3 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jul 30, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 30, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00